Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arash Hatefi

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Medical Oncology (Northwood, London, England)|March 2, 2023
Stem cell-assisted enzyme/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligandsGeng Li, Shahryar Khoshtinat Nikkhoi, Arash Hatefi
Frontiers in Oncology|February 6, 2025
Natural killer cell engagers for cancer immunotherapyShahryar Khoshtinat Nikkhoi, Geng Li, Arash Hatefi
International Journal of Pharmaceutics|December 4, 2012
Development of a novel histone H1-based recombinant fusion peptide for targeted non-viral gene deliveryFatemeh Soltani, Mojtaba Sankian, Arash Hatefi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 17, 2024
A quantitative MRI-based approach to estimate the permeation and retention of nanomedicines in tumorsAlireza Nomani, Siavash Yousefi, Davit Sargsyan, et al.
Protein Expression and Purification|March 20, 2017
Production of low-expressing recombinant cationic biopolymers with high purityXuguang Chen, Alireza Nomani, Niket Patel, et al.
International Journal of Pharmaceutics|February 21, 2012
Design, engineering and preparation of a multi-domain fusion vector for gene deliveryFaranak Sadeghian, Saman Hosseinkhani, Abdolali Alizadeh, et al.
Pharmaceutical Research|April 1, 2015
Reducing the Visibility of the Vector/DNA Nanocomplexes to the Immune System by Elastin-Like PeptidesFaranak S Nouri, Xing Wang, Xuguang Chen, et al.
Journal of Drug Targeting|December 13, 2016
An in vitro demonstration of overcoming drug resistance in SKOV3 TR and MCF7 ADR with targeted delivery of polymer pro-drug conjugatesPrashant Bhattarai, Dylan Vance, Arash Hatefi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 4, 2011
Development of targeted recombinant polymers that can deliver siRNA to the cytoplasm and plasmid DNA to the cell nucleusBrenda F Canine, Yuhua Wang, Wenyun Ouyang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 28, 2013
Incorporation of histone derived recombinant protein for enhanced disassembly of core-membrane structured liposomal nanoparticles for efficient siRNA deliveryYuhua Wang, Lu Zhang, Shutao Guo, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Medical Oncology (Northwood, London, England)|March 2, 2023
Stem cell-assisted enzyme/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligandsGeng Li, Shahryar Khoshtinat Nikkhoi, Arash Hatefi
Frontiers in Oncology|February 6, 2025
Natural killer cell engagers for cancer immunotherapyShahryar Khoshtinat Nikkhoi, Geng Li, Arash Hatefi
International Journal of Pharmaceutics|December 4, 2012
Development of a novel histone H1-based recombinant fusion peptide for targeted non-viral gene deliveryFatemeh Soltani, Mojtaba Sankian, Arash Hatefi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 17, 2024
A quantitative MRI-based approach to estimate the permeation and retention of nanomedicines in tumorsAlireza Nomani, Siavash Yousefi, Davit Sargsyan, et al.
Protein Expression and Purification|March 20, 2017
Production of low-expressing recombinant cationic biopolymers with high purityXuguang Chen, Alireza Nomani, Niket Patel, et al.
International Journal of Pharmaceutics|February 21, 2012
Design, engineering and preparation of a multi-domain fusion vector for gene deliveryFaranak Sadeghian, Saman Hosseinkhani, Abdolali Alizadeh, et al.
Pharmaceutical Research|April 1, 2015
Reducing the Visibility of the Vector/DNA Nanocomplexes to the Immune System by Elastin-Like PeptidesFaranak S Nouri, Xing Wang, Xuguang Chen, et al.
Journal of Drug Targeting|December 13, 2016
An in vitro demonstration of overcoming drug resistance in SKOV3 TR and MCF7 ADR with targeted delivery of polymer pro-drug conjugatesPrashant Bhattarai, Dylan Vance, Arash Hatefi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 4, 2011
Development of targeted recombinant polymers that can deliver siRNA to the cytoplasm and plasmid DNA to the cell nucleusBrenda F Canine, Yuhua Wang, Wenyun Ouyang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 28, 2013
Incorporation of histone derived recombinant protein for enhanced disassembly of core-membrane structured liposomal nanoparticles for efficient siRNA deliveryYuhua Wang, Lu Zhang, Shutao Guo, et al.
Pageof 5